SCHEMBL9459220

SCHEMBL9459220

C1=Cc2c(c3c4ccccc4c2CC3)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8663158 0.88 — —
SCHEMBL3419708 0.85 — —
SCHEMBL31488668 0.85 — —
SCHEMBL8662792 0.82 PARP1 (0.36) —
SCHEMBL22654590 0.76 ALDH1A1 (0.36) —
SCHEMBL23009940 0.74 — —
SCHEMBL22476048 0.74 ELANE (0.37) —
SCHEMBL21756035 0.74 — —
SCHEMBL23009848 0.73 CCNB2 (0.34) —
SCHEMBL25517258 0.73 PARP1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1159107-C Phosphor, arsenic and antimony compounds based upon diaryl-anellated bicyclo 2.2.N8cexcl, parent substances and catalysts contg. same �����ɷ� 2004-07-28 — — CN disclosed
CN-1398200-A Phosphor, arsenic and antimony compounds based upon diaryl-anellated bicyclo 2.2.N8cexcl, parent substances and catalysts contg. same BASF AG (DE) 2003-02-19 — — CN disclosed
CN-1278789-A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors ROCHE DIAGNOSTICS GMBH (DE) 2001-01-03 — — CN disclosed
US-5192762-A Nervous system disorders GRAY NANCY M (US) 1993-03-09 — — US disclosed
US-5055468-A Treating central nervous system disorders G. D. SEARLE & CO. (US) 1991-10-08 — — US disclosed
Send feedback